Skip to main content

Duration of Acceptable Delay Between the Time of Diagnosis and Treatment of Melanoma, Cutaneous Squamous Cell Carcinoma, and Basal Cell Carcinoma

Meer van Journal of the European Academy of Dermatology and Venereology
Home

Oncologieportal

Gerelateerd

  • FDA Updates Reports of Breast Implant-Related Cancer, Illness
  • Hydrochlorothiazide Label Warns of Risk for Non-Melanoma Skin Cancers
  • Is ovarian cancer surgery stuck in the dark ages?: a commentary piece reviewing surgical technologies

Tags

Trending

  • Radio 1's Adele Roberts reveals life with a stoma
  • Biology-Guided Precision Medicine in Rare Cancers: Lessons from Sarcomas and Neuroendocrine Tumours
  • Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort
  • Roche’s Polivy receives EC approval for lymphoma therapy
  • AML with t(8;16) mimicking acute promyelocytic leukaemia
  • Association between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed before 50 years According to Tumor Location

Log in met Medi-Access

Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen

Login Registreren

Duration of Acceptable Delay Between the Time of Diagnosis and Treatment of Melanoma, Cutaneous Squamous Cell Carcinoma, and Basal Cell Carcinoma

Journal of the European Academy of Dermatology and Venereology | Geplaatst op 24.01.2022 10:16

Abstract

-